This invention relates to the application of a
traditional Chinese medicine composition in the preparation of a
drug for treating
intestinal injury. The
traditional Chinese medicine composition comprises: 50-150 parts of
ginseng, 60-180 parts of
polygonatum, 40-90 parts of atractylodes, 30-58 parts of
sophora flavescens, 60-180 parts of
ophiopogon japonicus, 60-110 parts of
rehmannia glutinosa, 40-90 parts of
polygonum multiflorum, 60-180 parts of
cornus officinalis, 40-90 parts of poria cocos, 35-58 parts of
eupatorium fortunei, 35-58 parts of
coptis chinensis, 35-90 parts of
anemarrhena asphodeloides, 35-58 parts of
epimedium, 40-110 parts of
salvia miltiorrhiza, 60-180 parts of
kudzu root, 80-140 parts of litchi seed, and 40-90 parts of
lycium chinense root
bark. The above-mentioned
traditional Chinese medicine composition can inhibit the expression of TNF, AGE-RAGE, TLR and IL-17 and the infiltration of macrophages. It also helps to regulate the proliferation and differentiation of intestinal cells, restore
beneficial bacteria in the intestine, and significantly improve the
barrier function of the intestine, thereby effectively improving the damaged intestinal function.